Dr. Jeff Miller of Phoenix Children’s Joins SyntheticMR’s Medical Advisory Board

SyntheticMR is thrilled to announce the appointment of Dr. Jeff Miller to their Medical Advisory Board. 

Dr. Miller is the Chief of Radiology and a Pediatric Neuroradiologist at Phoenix Children’s Hospital in Arizona. He completed his Diagnostic Radiology residency training at St. Louis University School of Medicine and a fellowship in Diagnostic Neuroradiology at the Mallinckrodt Institute of Radiology. In addition to his duties at Phoenix Children’s, he is a Clinical Assistant Professor of Radiology at the University of Arizona College of Medicine, Mayo Clinic Scottsdale, and the Barrow Neurological Institute. 

Dr. Miller is a member of the American Society of Neuroradiology (ASNR), the International Society of Magnetic Resonance in Medicine (ISMRM), and the American Society of Pediatric Neuroradiology (ASPNR). Additionally, he is a member of the Industry Relations and Research Award Committees of the American Society of Pediatric Neuroradiology. He was awarded to the Best Doctors database in 2010 and received the ASPNR Pediatric Neuroradiology Research Grant Award in 2007.

“I am very excited to join SyntheticMR’s medical advisory board,” says Dr. Miller. “I am looking forward to working with their team on developing and further refining quantitative MRI applications within pediatrics.”

As a Medical Advisory Board member, Dr. Miller will help guide SyntheticMR’s product management and strategic initiatives using his extensive experience within clinical and academic radiology as well as pediatrics and neuroradiology.

“As a rapidly growing global company, our feedback from our users is essential to our success,” says Kyle Frye, President & CCO at SyntheticMR. “Dr. Miller’s expert advice will be critical to our innovation as we seek to support a faster and more reliable diagnosis of patients worldwide.”

“We work closely with our customers to ensure our product fit their needs and adds true clinical value,” says Ulrik Harrysson, CEO SyntheticMR. “Dr Miller’s input will be extremely valuable to us as we continue to set a new standard of care within pediatric neuroimaging.”
 

For additional information, please contact Ulrik Harrysson, CEO, SyntheticMR AB, +46 70 529 29 87 ulrik.harrysson@syntheticmr.com or Kyle Frye, President SyntheticMR Inc. at +1 (859) 512-9496 or kyle.frye@syntheticmr.com.

SyntheticMR AB develops and markets innovative software solutions for Magnetic Resonance Imaging (MRI). SyntheticMR AB has developed SyMRI^®, delivering multiple, adjustable contrast images and quantitative data from a single 5-minute scan. The SyMRI product is available in different packages. SyMRI NEURO delivers multiple contrast images, tissue segmentations and quantitative data on the brain. SyMRI MSK provides multiple contrast images and quantitative data for knee and spine anatomies. SyMRI NEURO is CE-marked and FDA 510(k) cleared and SyMRI MSK is CE-marked. SyMRI is a registered trademark in Europe and the USA. SyntheticMR is listed on the Spotlight Stock Market Exchange in Stockholm, Sweden. For more information, visit www.syntheticmr.com.